Results 91 to 100 of about 683,219 (354)
Ziying Wang,1,* Leilei Han,2,* Mingyi Dong,3 Yunman Liu,2 Xiangsui Hu,1 Long Huang,4 Chunquan Zhang,1 Liangyun Guo,1 Shengbo Liu,5 Lingmin Liao1 1Department of Ultrasound, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang ...
Wang Z+9 more
doaj
ENTPD5‐mediated conversion of extracellular adenosine triphosphate to ADP of hepatocytes is critical for maintaining hepatic glucose/lipid metabolism and promoting brown adipose tissue thermogenesis via the inhibition of adrenomedullin expression and secretion.
Rufeng Ma+9 more
wiley +1 more source
An analysis of the use of acute hospital resources, by the residents of Bexley and Greenwich [PDF]
An analysis was conducted of the use of acute hospital resources by the residents of the two Boroughs of Bexley and Greenwich. The data related to hospital episode statistics for 1996/97.
Marchant, M., Plant, Paul
core
Inducing ferroptosis is a promising strategy for combating tumor resistance. Upregulated PIP5K1A competes with NRF2 for KEAP1 binding, which decreases the ubiquitination degradation of NRF2 and promotes its nuclear translocation, thereby suppressing ferroptosis, and ultimately driving hepatocellular carcinoma (HCC) tumorigeneses and sorafenib ...
Mengzhou Guo+9 more
wiley +1 more source
Probiotic‐enhanced porous bio‐hybrids (E‐xPAM@ASA), developed by coupling the drug‐loaded hairy microporous nanospheres xPAM@ASA with probiotic EcN, integrate inflammatory‐targeting, ROS scavenging, and long‐term release of 5‐ASA to improve inflammation and regulate microbiota structure in the DSS‐induced colitis model, providing an advanced strategy ...
Luna Quan+7 more
wiley +1 more source
Gastroenterology Research and Practice
doaj +1 more source
6-thioguanine treatment in inflammatory bowel disease: A critical appraisal by a European 6-TG working party [PDF]
Recently, the suggestion to use 6-thioguanine (6-TG) as an alternative thiopurine in patients with inflammatory bowel disease (IBD) has been discarded due to reports about possible (hepato) toxicity. During meetings arranged in Vienna and Prague in 2004,
A. Teml+52 more
core +1 more source
This Month in Gastroenterology [PDF]
Laura, Harrell, Eugene B, Chang
openaire +6 more sources
ICAM1 antibody‐bound ICG triggers tumor‐specific, caspase‐1‐independent pyroptosis via CTSS‐mediated GSDMD cleavage, activates antitumor immunity, and synergizes with anti–PD‐1 therapy, offering a non‐apoptotic strategy to overcome resistance in cancer treatment.
Fan Chen+17 more
wiley +1 more source
This month in Gastroenterology [PDF]
Karen E. Kim, Thomas A. Brasitus
openaire +3 more sources